MIRacle™ hsa-miR-224-5p miRNA Agomir/Antagomir is a chemically modified synthetic oligonucleotide developed to precisely modulate the activity of endogenous microRNAs. The Agomir functions as a miRNA mimic, effectively enhancing the expression and biological activity of hsa-miR-224-5p. Whereas the Antagomir serves as a sequence-specific antagonist, inhibiting hsa-miR-224-5p function. Both formulations are optimized for high stability and efficacy in in vitro and in vivo settings. AcceGen provides the MIRacle™ series in multiple specifications (2 OD, 4 OD, 50 OD) with HPLC purification to accommodate a diverse range of experimental requirements. These reagents are ideal for investigating the role of hsa-miR-224-5p in key biological processes such as inhibition of osteoblast differentiation, impairment of bone formation, and promotion of tumorigenesis, including its contribution to the progression of thyroid carcinoma. They offer valuable insights into the molecular pathways regulated by hsa-miR-224-5p in skeletal biology and cancer development.
Inquiring MIRacle™ hsa-miR-224-5p miRNA Agomir/Antagomir
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research
